| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/2009 | CN101507727A Traditional Chinese medicine composite capable of reducing blood fat and preparation method thereof |
| 08/19/2009 | CN101507726A Association of a sinus If current inhibitor and a beta blocker |
| 08/19/2009 | CN101507725A Use of stephanine and hydrochloride thereof in preparing anti-hepatitis virus medicine |
| 08/19/2009 | CN101507724A Use of pyrroloquinoline quinine in antiradiation |
| 08/19/2009 | CN101507723A Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof |
| 08/19/2009 | CN101507722A Combination for treating coronary heart disease angina |
| 08/19/2009 | CN101507721A Postprandial hyperglycemia-improving agent |
| 08/19/2009 | CN101507720A Methods of modulating angiogenesis and cancer cell proliferation |
| 08/19/2009 | CN101507719A Vitamin C film-coat preparation and preparation method thereof |
| 08/19/2009 | CN101507718A Sodium rabeprazole enteric-coated orally disintegrating tablets and preparation method thereof |
| 08/19/2009 | CN101507716A Nifedipine sustained-release preparation and preparation method thereof |
| 08/19/2009 | CN101507715A Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof |
| 08/19/2009 | CN101507714A Oral preparation containing 7,9-dihydroxy-15-carbonyl-16-kaurene -19,6-lactone |
| 08/19/2009 | CN101507713A High bioavailability proton pump inhibitor sustained-release technique |
| 08/19/2009 | CN101507711A Ligustrazine micro-spheres and preparation method thereof |
| 08/19/2009 | CN101507708A Preparation method of liposome |
| 08/19/2009 | CN101507707A Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof |
| 08/19/2009 | CN101507706A Biodegradable in-situ solidification sustained-release injector |
| 08/19/2009 | CN101507705A Preparation method of block polymer micelle administration system with targeting effect |
| 08/19/2009 | CN101507704A Lutein solid dispersoid and preparation method thereof |
| 08/19/2009 | CN100530742C Method of doping organic semiconductors with quinonediimine derivatives |
| 08/19/2009 | CN100530268C Exercise support instrument |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529043C Ampelopsin healthcare wine |
| 08/19/2009 | CN100528933C Calcium polyaspartate and preparation method thereof |
| 08/19/2009 | CN100528901C Method for separating polysaccharide against growth of cancer cells from dictyophord |
| 08/19/2009 | CN100528894C 15-(14-deoxy 11,12 dehydro) andrographolide carbonic side derivate and preparation process thereof |
| 08/19/2009 | CN100528889C 1-0-caffeoyl -6-0-(S)-caesalpinia sepiaria acyl group -Beta-D-glucopyranose and uses thereof |
| 08/19/2009 | CN100528888C Novel anticonvulsant derivative salts |
| 08/19/2009 | CN100528886C Metal complex with liriodenine as ligand and its synthesis process and use |
| 08/19/2009 | CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/19/2009 | CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same |
| 08/19/2009 | CN100528877C New purine alkaloid and preparation method and application thereof |
| 08/19/2009 | CN100528876C Pyrrazolo-pyrimidine derivatives |
| 08/19/2009 | CN100528875C Crystal-free type Idi prone and its preparing method |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528872C Tetrahydro-proto-berberine compounds, their preparing method, composition and use |
| 08/19/2009 | CN100528871C Benzothiazole derivatives as adenosine receptor ligands |
| 08/19/2009 | CN100528870C Internal ester monomer compound and its application in preparing anti cancer medicine |
| 08/19/2009 | CN100528869C Silybin flavonolignan and their production method and use |
| 08/19/2009 | CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 08/19/2009 | CN100528864C N-substituted-2-oxodihydropyridine derivative |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528849C Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
| 08/19/2009 | CN100528844C Huperzine A derivative, preparation method and application thereof |
| 08/19/2009 | CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 08/19/2009 | CN100528841C Sulfonamide compound |
| 08/19/2009 | CN100528835C Crystalline form of beta2 adrenergic receptor agonist |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528824C Beta-elemene monosubstituted ether derivatives, synthesis method and use thereof |
| 08/19/2009 | CN100528326C Method for preparing anti-oxidant bio-microcapsule |
| 08/19/2009 | CN100528318C Granules comprising a beta-lactam antibiotic |
| 08/19/2009 | CN100528264C Health gauze mask |
| 08/19/2009 | CN100528237C Preparation of polynuclear iron hydroxide-sugar composite |
| 08/19/2009 | CN100528234C Lactobionic acid azithromycin for injections and preparation method thereof |
| 08/19/2009 | CN100528233C Process for producing coated preparation having relieved unpleasantness |
| 08/19/2009 | CN100528232C Pharmaceutical preparation in form of suspension comprising acid-labile active ingredient |
| 08/19/2009 | CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/19/2009 | CN100528217C Effective germinal liquid |
| 08/19/2009 | CN100528214C Capsule for treating epilepsia and its preparing method |
| 08/19/2009 | CN100528195C Preparation of dyers woad root injection |
| 08/19/2009 | CN100528194C Medicine for treating femoral head necrosis |
| 08/19/2009 | CN100528188C Chinese traditional medicinal anesthetics |
| 08/19/2009 | CN100528183C Capsule for treating gout |
| 08/19/2009 | CN100528177C Red yeast preparation containing active components of glossy ganoderma and its preparation process |
| 08/19/2009 | CN100528176C Chinese traditional medicinal composition for treating acne |
| 08/19/2009 | CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof |
| 08/19/2009 | CN100528173C 4'-substituted nucleosides |
| 08/19/2009 | CN100528172C Oral medicine for treating turtle parotiditis |
| 08/19/2009 | CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 08/19/2009 | CN100528170C Mangiferin preparation and production thereof |
| 08/19/2009 | CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 08/19/2009 | CN100528168C 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/19/2009 | CN100528167C Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| 08/19/2009 | CN100528166C Portal hypertension inhibitor |
| 08/19/2009 | CN100528165C Stable medicine composition of setastine or its salt |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/19/2009 | CN100528163C Oral cavity disintegration tablet for treating gout and its preparation method |
| 08/19/2009 | CN100528162C Pharmaceutical compositions |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528160C An antibacterial rifampicin nanoemulsion and preparation method thereof |
| 08/19/2009 | CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases |
| 08/19/2009 | CN100528158C Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
| 08/19/2009 | CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 08/19/2009 | CN100528156C Prevention of addiction in pain management |
| 08/19/2009 | CN100528155C Nanometer berberine hydrochloride emulsion and its preparation process |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/19/2009 | CN100528153C Percutaneous absorption type cerebral protective agent |
| 08/19/2009 | CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 08/19/2009 | CN100528151C Pharmaceutical formulations of modafinil |
| 08/19/2009 | CN100528150C Novel pharmaceutical formulations of modafinil |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/19/2009 | CN100528144C Aceclofenac in extended-released tablets and method of manufacturing the same |
| 08/19/2009 | CN100528141C Freeze dried ligustrazine hydrochloride preparation for injection and its preparation process |
| 08/19/2009 | CN100528140C Stable shaped particles of crystalline organic compounds and preparation method thereof |
| 08/19/2009 | CN100528139C Preserved ophthalmic compositions |
| 08/18/2009 | USRE40876 Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |